SCOPOLAMINE TRANSDE

The Defense Logistics Agency awarded a delivery order under contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the procurement of SCOPOLAMINE TRANSDE, with national stock number 6505014562380, at a total value of $130.96. The award was issued on July 14, 2026, with a required delivery date of July 29, 2026. The item is to be delivered FOB Destination to Fort Campbell, Kentucky, with the contractor responsible for all transportation costs and risk of loss until delivery. Packaging and shipping must comply with traceability requirements, including labeling with CAGE code, part number, NSN, and NDC, and parcel post is strictly prohibited. Invoicing must follow DFARS 252.232-7003, requiring electronic submission through the Defense Financial Accounting Service system, and payment is to be remitted to the designated office in Columbus, Ohio. The government retains final inspection and acceptance authority at the delivery point, with no formal quality standards beyond contractual conformity specified. The contract reflects a single-line, fixed-price delivery order with no options, quantities, or variability, indicating a low-value, routine replenishment transaction. The NAICS code 424210 classifies the awardee as a pharmaceutical merchant wholesaler, and while socioeconomic status and unique entity ID are not explicitly stated, the CAGE code is confirmed. Contract administration is managed by Lisa Quinn, Contracting Officer, with administrative support provided by Shairy M. Cartagena. No formal sections detailing contract clauses, evaluation factors, attachments, special requirements, or solicitation instructions were found in the available documentation, suggesting the delivery order was issued under an existing procurement vehicle with minimal additional requirements.